PKCβII Peptide Inhibitor I structure
|
Common Name | PKCβII Peptide Inhibitor I | ||
|---|---|---|---|---|
| CAS Number | 862502-26-9 | Molecular Weight | 1299.47000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C61H94N12O19 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PKCβII Peptide Inhibitor IPKCβII Peptide Inhibitor I is a PKCβII inhibitor. PKCβII Peptide Inhibitor I shows cardioprotective effects in rat cardiac Ischemia/reperfusion injury model. PKCβII Peptide Inhibitor I also prevents vascular endothelial dysfunction[1]. |
| Name | L-Threonine, N-(1-oxotetradecyl)-L-seryl-L-leucyl-L-asparaginyl-L-prolyl-L-α-glutamyl-L-tryptophyl-L-asparaginyl-L-α-glutamyl |
|---|---|
| Synonym | More Synonyms |
| Description | PKCβII Peptide Inhibitor I is a PKCβII inhibitor. PKCβII Peptide Inhibitor I shows cardioprotective effects in rat cardiac Ischemia/reperfusion injury model. PKCβII Peptide Inhibitor I also prevents vascular endothelial dysfunction[1]. |
|---|---|
| Related Catalog | |
| Target |
PKCβII[1] |
| References |
| Molecular Formula | C61H94N12O19 |
|---|---|
| Molecular Weight | 1299.47000 |
| Exact Mass | 1298.68000 |
| PSA | 507.44000 |
| LogP | 3.73080 |
| PKCBetaII Peptide Inhibitor I trifluoroacetate salt |
| PKCSSII PEPTIDE INHIBITOR I TRIFLUOROACETATE SALT |
| PKCBII PEPTIDE INHIBITOR I TRIFLUOROACE |